Procoagulant and fibrinolytic activity in cerebrospinal fluid from adults with bacterial meningitis

Journal of Infection

Volumn 54, Issue 6, 2007, Pages 545-550

  Weisfelt, Martijn ^a   Determann, Rogier M ^a   de Gans, Jan ^a   van der Ende, Arie ^a   Levi, Marcel ^a   van de Beek, Diederik ^a   Schultz, Marcus J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bacterial meningitis; Cerebrospinal fluid; Coagulation; Fibrinolysis; Outcome; Viral meningitis

Indexed keywords

AMOXICILLIN; CEPHALOSPORIN DERIVATIVE; D DIMER; DEXAMETHASONE; FIBRIN; IMMUNOSUPPRESSIVE AGENT; PENICILLIN G; PLASMA PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM CULTURE; BLOOD CLOTTING; BRAIN INFARCTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FIBRINOLYSIS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MONOTHERAPY; NEUROLOGIC EXAMINATION; NONHUMAN; PNEUMONIA; PROSPECTIVE STUDY; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION; VIRUS MENINGITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; CHILD; COAGULANTS; COHORT STUDIES; FEMALE; FIBRINOLYSIS; HUMANS; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED;

EID: 34248388534     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2006.11.016     Document Type: Article

References (13)

1. Van de Beek D., de Gans J., Spanjaard L., Weisfelt M., Reitsma J.B., and Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351 (2004) 1849-1859
2. Van de Beek D., De Gans J., Tunkel A.R., and Wijdicks E.F. Community-acquired bacterial meningitis in adults. N Engl J Med 354 (2006) 44-53
3. Van de Beek D., Schmand B., De Gans J., Weisfelt M., Vaessen H., Dankert J., et al. Cognitive impairment in adults with good recovery after bacterial meningitis. J Infect Dis 186 (2002) 1047-1052
4. Weisfelt M., Van de Beek D., Spanjaard L., Reitsma J.B., and de Gans J. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol 5 (2006) 123-129
5. Levi M., Van der Poll T., and Buller H.R. Bidirectional relation between inflammation and coagulation. Circulation 109 (2004) 2698-2704
6. Levi M., and Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 341 (1999) 586-592
7. Schultz M.J., Millo J., Levi M., Hack C.E., Weverling G.J., Garrard C.S., et al. Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax 59 (2004) 130-135
8. Winkler F., Kastenbauer S., Koedel U., and Pfister H.W. Increased serum concentrations of tissue plasminogen activator correlate with an adverse clinical outcome in patients with bacterial meningitis. J Neurol Neurosurg Psychiatr 73 (2002) 456
9. Winkler F., Kastenbauer S., Koedel U., and Pfister H.W. Role of the urokinase plasminogen activator system in patients with bacterial meningitis. Neurology 59 (2002) 1350-1355
10. Weisfelt M., De Gans J., Van der Poll T., and Van de Beek D. Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol 5 (2006) 332-342
11. Hoekstra T., Geleijnse J.M., Schouten E.G., and Kluft C. Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk. Thromb Haemost 91 (2004) 861-872
12. Lindgren A., Lindoff C., Norrving B., Astedt B., and Johansson B.B. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke 27 (1996) 1066-1071
13. Roos Y.B.W.E.M., Levi M., Carroll T.A., Beenen L.F.M., and Vermeulen M. Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage. Stroke 32 (2001) 1860-1862